Mode
Text Size
Log in / Sign up

PA-VLLF ChatGPT architecture achieves 86.36% accuracy in pediatric pain assessment comparable to senior expertsAI Model Matches Senior Experts in Assessing Children's Pain

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that PA-VLLF ChatGPT achieves 86.36% accuracy in pediatric pain scoring, comparable to senior experts.

This guideline outlines a proof-of-concept study evaluating the Pain Assessment Vision-Large Language Framework (PA-VLLF) using ChatGPT-4o and Qwen2-VL architectures. The framework was designed to generate FLACC scores for children undergoing venipuncture, aiming to provide a standardized tool to reduce cognitive burden and mitigate rater variance in pediatric pain evaluation.

The primary finding indicates that PA-VLLF-ChatGPT achieved an accuracy of 86.36% on expert-labeled scores. This performance was statistically comparable to senior experts (84.69%, p > 0.05). Secondary outcomes included the precision of pain-level assessment measured by MAX agreement and Z-Score, though specific values for these metrics were not reported.

As a proof-of-concept study based on an observational dataset of 1,248 video segments from 104 children, the evidence is preliminary. The results suggest that PA-VLLF may serve as a consensus-based intelligent assistant to standardize pain assessment in pediatric settings. However, further validation is required to establish its reliability in diverse clinical environments.

Researchers tested a new artificial intelligence system designed to help healthcare workers measure pain in children. The study focused on 104 children who were undergoing venipuncture, which is the process of starting an IV or drawing blood. The researchers used video segments to see if the AI could accurately score pain levels using a standard scale called FLACC.

The results showed that the AI model achieved an accuracy rate of 86.36 percent. This performance was comparable to the scores given by senior experts, who scored at 84.69 percent. Because the difference between the two groups was not statistically significant, the tool performed similarly to human experts in this specific test.

This study is a proof-of-concept based on an observational dataset of video segments. While the AI shows promise as a way to reduce the workload for staff and provide consistent results, it is still an early stage of development. It is intended to serve as a tool to help ensure consistent pain assessments in pediatric care.

What this means for you:
An AI model showed accuracy comparable to senior experts when assessing children's pain during needle procedures.

Common questions

How accurate is the AI at measuring children's pain?

The AI system achieved an accuracy of 86.36 percent when assessing pain scores for children. This result was comparable to the 84.69 percent accuracy rate achieved by senior experts. The study found no significant difference between the performance of the AI and the human experts in this specific test.

Who is this technology intended to help?

The tool is designed to assist healthcare workers who treat children. It aims to reduce the mental workload for staff and provide a consistent way to measure pain, which can help reduce differences in how different people might rate a child's discomfort during procedures like venipuncture.

Is this AI tool ready to replace human doctors?

No, the study is currently a proof-of-concept based on an observational dataset of video segments. It is intended to serve as an intelligent assistant to help provide consistent results, rather than replacing the judgment of medical professionals.

Study Details

Study typeGuideline
EvidenceLevel 5
PublishedJul 2026
View Original Abstract ↓
BackgroundAccurate pediatric pain assessment is essential for effective pain management and procedural safety. However, current evaluations largely rely on subjective scales and casual behavioral observations. Although automated pain assessment methods have been proposed, they often remain complex and less reliable than expert clinicians. This study aimed to establish a proof-of-concept for a novel Pain Assessment Vision–Large Language Framework (PA-VLLF) for consistent pediatric pain evaluation.MethodsIn this observational proof-of-concept study, we developed and validated the PA-VLLF using representative keyframes extracted from real-world surveillance video recordings of venipuncture from two camera angles. The foundation framework combined ChatGPT-4o and Qwen2-VL vision-language architectures, with customized prompts and fine-tuning to generate FLACC (Facial, Legs, Activity, Cry, Consolability) scores within a human-in-the-loop framework. Data were collected and analyzed from September to December 2024. The study was approved by the institutional review board (IRB no. 294A01) and parental consent was obtained.ResultsWe established a Clinical Pain Assessment (CPA) dataset of 1,248 video segments from 104 children, independently annotated by five certified pain experts over a cumulative 950 person-hours to establish a consensus baseline. In this dataset, PA-VLLF-ChatGPT successfully aligned with the collective expert consensus, achieving 86.36% accuracy on expert-labeled pain scores, performing comparably to senior experts (84.69%, p > 0.05) and outperforming machine-learning approaches in our comparisons; precision of pain-level assessment was evaluated using complementary metrics (MAX agreement and Z-Score).ConclusionsAs a successful proof-of-concept, PA-VLLF demonstrates that vision-language models can successfully internalize expert-derived clinical reasoning. By serving as a standardized, consensus-based intelligent assistant, it reduces the cognitive burden of complex visual evaluations and mitigates individual rater variance. This framework holds promise for improving pain management strategies, supporting highly consistent, AI-assisted clinical decision-making. To support future research, the CPA dataset will be accessible upon the publication of this article to qualified researchers under data privacy regulations.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.